Cartesian Therapeutics, Inc. (RNAC)
NASDAQ
$8.18-0.97%
As of Jul 20, 2026
Price history
Key statistics
- Market cap
- —
- P/E ratio
- —
- EPS
- —
- Volume
- 113,887
- 52-week high
- —
- 52-week low
- —
- Open
- $8.33
- Day high
- $8.48
- Day low
- $8.03
Financial highlights
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| 2025 | $400K | -$130.3M | -$5.02 |
| 2024 | $38.28M | -$77.42M | -$4.49 |
| 2023 | $26M | -$219.71M | -$49.76 |
| 2022 | $110.78M | $35.38M | $0.10 |
| 2021 | $85.08M | -$25.69M | -$0.22 |
About Cartesian Therapeutics, Inc.
A company overview for Cartesian Therapeutics, Inc. is coming soon.
Similar stocks
Related stocks will appear here soon.
Frequently asked questions
- What is Cartesian Therapeutics, Inc.'s stock price today?
- RNAC is trading at $8.18 as of Jul 20, 2026.
- Does Cartesian Therapeutics, Inc. pay a dividend?
- Cartesian Therapeutics, Inc. did not pay a dividend in its most recent reported fiscal year.